Device Alliance Ii_endo

Alliance II

Payments companies reported to CMS as associated with Alliance II. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$779associated payments (2023-2025)
25clinicians with associated payments
1company reporting

By year

2023 $104
2024 $463
2025 $212

Payments reported as associated with Alliance II, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $695
Nurse Anesthetist, Certified Registered $45.08
Women'S Health (Nurse Practitioner) $15.65
Neonatal (Nurse Practitioner) $4.74

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Alliance II

These are the largest totals companies reported as associated with Alliance II. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mitchell Kaplan Arlington Heights, IL Gastroenterology (Internal Medicine) $93.77
Nicolas Villa Guillen Spokane, WA Gastroenterology (Internal Medicine) $59.10
Stephen Kelly Conroe, TX Gastroenterology (Internal Medicine) $58.72
Serge Awasum Shenandoah, TX Gastroenterology (Internal Medicine) $58.72
Matthew Clark Shenandoah, TX Gastroenterology (Internal Medicine) $58.72
Apurv Varia The Woodlands, TX Gastroenterology (Internal Medicine) $58.72
Shail Maheshwari Shenandoah, TX Gastroenterology (Internal Medicine) $58.72
Sunil Reddy Conroe, TX Gastroenterology (Internal Medicine) $58.72
Rambabu Chalasani Houston, TX Gastroenterology (Internal Medicine) $58.72
Rebecca Voaklander Salt Lake City, UT Gastroenterology (Internal Medicine) $20.50

Prescribed Alliance II?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.